Ginkgo Bioworks Holdings Operating Income 2020-2023 | DNA
Ginkgo Bioworks Holdings operating income from 2020 to 2023. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Ginkgo Bioworks Holdings Annual Operating Income
(Millions of US $) |
| 2022 |
$-2,209 |
| 2021 |
$-1,828 |
| 2020 |
$-137 |
| 2019 |
$-72 |
Ginkgo Bioworks Holdings Quarterly Operating Income
(Millions of US $) |
| 2023-03-31 |
$-216 |
| 2022-12-31 |
$-234 |
| 2022-09-30 |
$-653 |
| 2022-06-30 |
$-647 |
| 2022-03-31 |
$-675 |
| 2021-12-31 |
$-1,685 |
| 2021-09-30 |
$-27 |
| 2021-06-30 |
$-60 |
| 2021-03-31 |
$-57 |
| 2020-12-31 |
|
| 2020-09-30 |
$-34 |
| 2019-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$3.379B |
$0.478B |
|
Ginkgo Bioworks platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo Bioworks, formerly known as Soaring Eagle Acquisition Corp., is based in NEW YORK.
|
